Over 1,100 drug discovery professionals will convene for BostonDOT20 in the biotech hub of Boston this September 15-18, 2020. Join the community and be part of the 2020 experience. Learn more: https://bit.ly/2Voawnw
35+ presentations given at the 2019 meeting. Over two days discovered more about the latest advances and applications of digital pathology. Learnt how artificial intelligence and machine learning is being applied to primary diagnosis and clinical research and how the image-based information environment is transforming the laboratory.
Bentham Science is offering 20% discounts on purchasing eBooks and subscriptions on Journals to delegates attending the conference
29-31 October 2018, EPIC SANA Lisboa Hotel, Lisbon, Portugal
Temperature Maintenance of Pharmaceuticals in Distribution is back! The 13th annual edition will bring together industry peers to discuss and discover potential solutions to the biggest challenges within temperature control, transportation obstacles or regulatory compliance. We will have representatives from UCB Pharmaceuticals, Merck Serono, Shire, Genzyme or IATA, amongst many others. The event is also co-located with the prestigious Clinical Trial Supply Europe conference.
Find more details here: http://www.arena-international.com/pharmatemp
Related eBook: Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook
Following the overwhelming success of our 2016 event, Clinical Trial Supply Europe is returning to Barcelona for its 17th year. March 2017 will see the flagship CTS event offering two streams of top speakers to assist you in overcoming your persistent clinical supply challenges. Offering operational and technological specific sessions throughout the two day event, there truly is something for everyone at CTS.
Find more details here: http://www.arena-international.com/ctseurope/
Related eBook: Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook
16th Annual Strategic Project & Portfolio Management for Pharma on 25-27 January 2017, Barcelona, Spain.
Build a Solid Portfolio Infrastructure to Adapt to Changes and Prevent Risks, Proceed with the Right Decision, Maximize Value under Tight Budget and Resources, Develop Synergies and Opportunities on New Markets.
As the strategic and operating environment for Pharmaceutical R&D becomes more cost-constrained and evolving portfolios require increasingly more investment, critical decision-making and methodology is evidently a crucial element in PPM.
The conference will look at how to structure portfolio management into the organization, how to transform R&D indicators and PPM parameters into successful revenue producing projects and portfolios that align corporate business goals. This year approach will be both on technical side, on understanding how right processes, realistic analysis and correct interpretation of data can be translated into market success; but also how organizational aspects, how capacity management, leadership skills can build high performing teams and strategic decision making.
Importantly, this conference will not neglect the other essential topics including prioritization, internal resource management, risk management and especially de-risking strategies (partnerships, outsourcing) as main factor of market success, managing pipeline from early stage to commercial stage, with a view on market access and generic portfolio management.
Find more detail: https://goo.gl/CaYgDj
Related eBook: Frontiers in Medicinal Chemistry & Frontiers in Anti-Cancer Drug Discovery
PHARM Connect Congress 2017 (November 2016 issue)
Boost your business in 2017 by presenting your solutions to the top pharmaceutical and biotechnology decision makers in Central Eastern Europe!
TEG – organizer of the most important pharmaceutical and and biotechnology business summit in CEE Pharm Connect Congress, with the support of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) – announces the 3rd Central Eastern European Pharmaceutical Manufacturing Excellence Award. The aim of the award is not only to celebrate excellence in manufacturing, but also to encourage professionals to constantly raise standards contributing to the development as well.
Applications from all members of the industry are welcome in two categories – innovative and generic pharmaceutical and biotechnology manufacturers in the first one, while service providers with a customer project in the second until the 16th of January 2017! The winners will have the opportunity to present their projects to the top pharmaceutical and biotechnology management professionals at PHARM Connect running on 22-23 February 2017 in Budapest between the walls of the prestigious Corinthia Grand Hotel Royal.
The two-days networking event allow participants to meet fellow decision makers playing key role in pharmaceutical and biotechnology companies from all over CEE as well as take part in round table discussions, presentations, enjoy relaxed networking opportunities as a member of the greatest professional hub of the region. Heads of plants, production, packaging, quality management, R&D, sterile technologies and contamination control, technical, maintenance, logistics, distribution, CEOs and many more from the most prominent pharmaceutical and biotech companies attend regulary to sit down for one-to-one business meetings, change business cards, discuss key topics of specific industry challenges and eshtablish new and fruitfull partnerships.
Industry pears usually have more meetings in 2 days than throughout a year, with professionals who are interested in what they have to offer!
For further information about PHARM Connect Congress please visit: www.pharmconnect.eu
Global Engage is pleased to announce the 4th Microbiome R&D and Business Collaboration Forum: Europe which will be held on 3-4 April 2017.
For more details visit: http://www.globalengage.co.uk/microbiota.html
The recent rare superbug outbreak in Wisconsin* which is now blamed for the deaths of 18 people has rendered the attention amongst superbug and superdrug professionals again. Despite advanced healthcare and antibiotics, more than 100,00 people die from hospital-acquired infections per year, which equates to 4% of patient populations in the US. Scientists now have to gear to combat on resistance to antimicrobials, implant-related resistant infections and mutation of bacterial. A recent study** stated that bacterial wall ‘gates’ could lead to new anti-superbug drugs. As such, SMi is excited to extend our premier Superbugs & Superdrugs conference to the US this November, providing a timely platform for both pharmaceutical and healthcare experts to share their research updates and insights in this subject – driving the rebuild of a global defensive wall of bacteria!
Registration is now live for this unmissable event. Visit http://www.superbugs-usa.com/bentham for more information.
Bentham Science 
You must be logged in to post a comment.